Streetbeat News

Stock Prices

PEAK

Barclays has maintained its Overweight rating for Healthpeak Properties (NYSE:PEAK) but lowered its price target from $33.00 to $32.00. Healthpeak Properties' shares are currently trading at $22.09, down 0.16% over the last 24 hours. A move to the new price target would represent a 44.89% increase from the current share price.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:01 pm

HUM

Humana (NYSE:HUM) has outperformed the market over the past 10 years by 7.14% on an annualized basis, producing an average annual return of 17.59%. If an investor had bought $1000 of HUM stock 10 years ago, it would be worth $4,977.38 today.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:00 pm

MBLY

Over the past 3 months, 16 analysts have published their opinion on Mobileye Global (NASDAQ:MBLY) stock. The average price target for the stock is $46.94, a decrease of 1.76% from the previous average price target of $47.78. The majority of the ratings are bullish.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:00 pm

BMRC

DA Davidson has maintained its Neutral rating for Bank of Marin (NASDAQ:BMRC) and increased its price target from $20.00 to $21.00. The bank's shares are currently trading down 2.07% at $19.91 per share. A move to $21.00 would represent a 5.47% increase from the current share price.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:00 pm

NTES

NetEase (NASDAQ:NTES) has outperformed the market over the past 5 years by 5.17% on an annualized basis, producing an average annual return of 15.4%. If an investor had bought $1000 of NTES stock 5 years ago, it would be worth $2,005.21 today.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:00 pm

OPRT

BTIG has maintained its Buy rating for Oportun Financial (NASDAQ:OPRT) and increased its price target from $7.00 to $7.50. This represents a potential 21.75% increase from the current share price. However, shares of Oportun Financial have been trading down 2.22% over the last 24 hours.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:00 pm

PG

Over the past 3 months, 4 analysts have published their opinion on Procter & Gamble (NYSE:PG) stock. The company has an average price target of $166.5, a decrease of 1.29% from the previous average price target of $168.67. The ratings include 1 bullish, 2 somewhat bullish, and 1 indifferent.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:00 pm

ELV

Morgan Stanley has maintained its Overweight rating for Elevance Health (NYSE:ELV) and increased its price target from $571.00 to $585.00. Elevance Health, a leading health insurer in the U.S., is unique as the largest single provider of Blue Cross Blue Shield branded coverage. The company's reach expands beyond 14 states through government-sponsored programs such as Medicaid and Medicare Advantage plans.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 5:00 pm

SOUN

SoundHound AI has filed for a mixed shelf of up to $400 million, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 5:00 pm

AMC

AMC Entertainment Holdings has an option alert for August 4 $5 calls sweep near the ask: 2000 @ $0.52 vs 6395 open interest. The company's earnings will be announced after close on August 8. The reference price is $5.1721.

Portfolio Pulse from Charles Gross

July 25, 2023 | 4:56 pm